MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why INSP Stock advanced +0.30% Today — RQD Quant Desk Flash
$71.18 +0.30% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $71.08
Inspire Medical Systems Inc. (INSP) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C- • HOLD / WATCH
Cap $2.06B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $71.08 (-0.14%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 8.6% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY • 53.9% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C-
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-
Each axis scored 0–20
12M PRICE TARGET CONE+1.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for INSP)Realized 20D OHLCV Swing Band: ±8%
Deterministic 5-Pillar Attribution (61/100 Composite)
🔍 WHY INSP SCORES 61/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (30% of score)
Altman Z-Score 11.40 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (26% of score)
SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)
▼ #1 Drag / Risk Factor: Cash Engine Quality8/20 pts (-12 pt drag)
Capital intensity & 5.6% operating margin leave 12 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$68.89-0.1% Next Q
53
Q2 (-2Q)Grade C$68.79+3.4% Next Q
56
Q3 (-1Q)Grade C$71.11+0.1% Next Q
58
CurrentGrade C-$71.18+0.5% Hist 90D α
61
Trajectory: C- (53) → C- (61)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the INSP Bull Thesis Could Fail
Even with a 61/100 (C-) score, INSP faces multiple-compression risk if 14.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 82.9% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($68.59) or 200D SMA ($58.57) invalidates the momentum regime and cuts Target Base ($72.14) toward Bear Floor ($56.27).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $INSP• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “INSP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why INSP Stock advanced +0.30% Today — RQD Quant Desk Flash
Inspire Medical Systems Inc. (INSP) advanced +0.30% to $71.18, trading at 30% of its 52-week range ($38.91 – $147.03). Solid 85% profit margin (6% return on capital), mixed timing at 14x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 30% of its 52-week range ($38.91 – $147.03) with RSI-14 at 45.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8% around $71.18 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 85.4% gross margin and $78.5M annual free cash flow.
Live INSP Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (INSP Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
INSP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +26.79%🛡️ HOLDING TREND SUPPORT
2026-10-30O $70.63H $71.19L $67.80C $71.18VOL 796.4K
RES: $90.60SUP: $70.06SMA50: $68.59SMA200: $58.57
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
INSP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
6.0%/yr Implied 5Y Growth
vs. +13.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on INSP today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for INSP. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for INSP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (INSP)
Health Care Rank #183 of 1016
⚔️ LMAT vs INSP Full Matrix →
1. Head-to-Head Health Care Peer Comparison (INSP vs. LMAT, XRAY, UFPT, KMTS)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Inspire Medical Systems Inc. (INSP) ranks #183 by composite RQD confidence (61/100, grade C-) and #256 by equity capitalization ($2.06B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. UFPT currently holds the highest overall quantitative score in the immediate peer group at 81/100 (A-) compared with INSP at 61/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| INSP
ACTIVE
Inspire Medical Systems Inc. | C- | 61/100 | 14.2x | 85.4% | 6.0% | +0.30% | $2.06B | Benchmark Subject |
| LMAT LeMaitre Vascular Inc. | B | 74/100 | 33.8x | 71.5% | 14.7% | +2.90% | $1.95B | /lmat-vs-insp → |
| XRAY DENTSPLY SIRONA Inc. | D | 46/100 | — | 50.0% | -11.0% | +1.80% | $1.92B | /xray-vs-insp → |
| UFPT UFP Technologies Inc. | A- | 81/100 | 33.3x | 28.3% | 13.9% | +2.55% | $2.27B | /ufpt-vs-insp → |
| KMTS Kestra Medical Technologies Ltd. | D- | 43/100 | — | 51.4% | -35.0% | +2.48% | $1.82B | /kmts-vs-insp → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001609550In its most recent audited fiscal period (FY2025, filed 2025-12-31), Inspire Medical Systems Inc. (INSP) reported GAAP revenue of $912.0M (+13.6% vs. FY2024 revenue of $802.8M , and +46.0% cumulative change since FY2023) , GAAP net income of $145.4M, operating cash flow of $117.0M, and free cash flow of $78.5M (-13.9% YoY). On the balance sheet, INSP closed FY2025 with $907.3M in total assets against $0 in total debt (Altman Z-Score: 11.40, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $912.0M | $145.4M | $117.0M | $78.5M | $907.3M | — |
| FY2024 (FY) | 2024-12-31 | $802.8M | $53.5M | $130.2M | $91.1M | $808.4M | — |
| FY2023 (FY) | 2023-12-31 | $624.8M | -$21.2M | $24.7M | $24.7M | — | — |
3. INSP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs INSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Inspire Medical Systems Inc. (NYSE: INSP) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $71.18 (+0.30% 1D, market cap $2.06B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, INSP ranks #183 in composite RQD confidence.
How does INSP compare to LMAT and XRAY in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), INSP carries a Roarable C- (61/100 RQD), trailing P/E of 14.2x, gross margin of 85.4%, and ROIC of 6.0%. By comparison, LMAT (LeMaitre Vascular Inc.) holds a B grade (74/100 RQD, P/E 33.8x, ROIC 14.7%, cap $1.95B) and XRAY (DENTSPLY SIRONA Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for INSP?
Per INSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001609550), Inspire Medical Systems Inc. generated $912.0M in revenue (+13.6% YoY), $145.4M in net income, and $78.5M in free cash flow against $907.3M in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is INSP trading relative to its 50-day, 200-day, and 52-week technical levels?
INSP last traded at $71.18 (+0.30% on volume of 512,603 shares), positioning the stock +3.78% above its 50-day simple moving average ($68.59) and +21.53% above its 200-day simple moving average ($58.57). Across its 52-week range of $38.91 to $147.03, INSP sits at the 29.8% percentile with a 14-day RSI of 45.4 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($65.49 to $76.87).
INSP Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is INSP stock moving today?
Why INSP Stock advanced +0.30% Today — RQD Quant Desk Flash. Solid 85% profit margin (6% return on capital), mixed timing at 14x P/E—hold if owned, no rush to chase.